Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Synchron's BCI"


4 mentions found


Neurotech startup Synchron on Tuesday announced it has connected its brain implant to Apple 's Vision Pro headset. Apple released the Vision Pro earlier this year, and users typically control it with eye movements, voice commands and hand gestures. He said Synchron will likely work to connect its BCI to other headsets, but it's starting with the Vision Pro. Apple has been "very supportive" of the Vision Pro integration, he added. Synchron is a part of an increasingly competitive BCI industry, and the company said Tuesday that it is the first to connect its system to Apple's Vision Pro.
Persons: Synchron, Thomas Oxley, Oxley, Elon Musk's, It's Organizations: BCI, U.S . Food, Drug Administration, Apple, Vision, CNBC, Neuroscience, Blackrock Neurotech Locations: U.S, Australia
Mark using Synchron's BCI Courtesy: SynchronA 64-year-old named Mark has spent the last year learning how to control devices like his laptop and phone using a brain implant. Mark, who asked CNBC not to use his last name for privacy reasons, was implanted with Synchron's BCI in August 2023. H/O: Synchron's AI-Powered chat feature Courtesy: SynchronMark has been testing Synchron's new chat feature intermittently over the last two months. For instance, Mark can use the chat feature to schedule an appointment with his doctor and keep up with his daughters. Oxley said Synchron is still working to roll out the new chat feature, but Mark has helped pioneer it.
Persons: Mark, OpenAI, it's, Synchron, I've, Thomas Oxley, Oxley Organizations: BCI, CNBC, Synchron's BCI
The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. The in-human clinical trial marks just one step on Neuralink's path toward commercialization. Neuralink did not disclose how many human patients will participate in its initial in-human trial. Paradromics is aiming to launch its first trial with human patients in the first half of this year. Precision Neuroscience carried out its first in-human clinical study last year.
Persons: Elon, Neuralink, Musk, Stephen Hawking, Blackrock Neurotech, Tom Oxley's Organizations: U.S . Food, Drug Administration, FDA, SpaceX, BCI, Neuroscience, Paradromics, Blackrock Locations: U.S
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, using his BCI. Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. About 20 months earlier, O'Keefe was implanted with Synchron's BCI. Synchron's technology has caught the attention of its competitors. Source: SynchronIn January, the medical journal JAMA Neurology published the peer-reviewed, long-term safety results from a trial of Synchron's BCI system in Australia.
Total: 4